Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN PR versus OxyPR in osteoarthritis pain with constipation assessment
2008-002670-36Phase 3Completed
- Sponsor
- Mundipharma Research
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxycodone + naloxone and oxycodone in osteoarthritis (OA) (2 arms), sponsored by Mundipharma Research. Primary endpoint: Patient assessment of pain and locomotor function. Started Oct 2008; status: completed.
02
Drugs
oxycodone + naloxoneoxycodone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2008-002670-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002670-36.